Availability of ultraportable chest x-ray (CXR) and advancements in artificial intelligence (AI)-enabled CXR interpretation are promising developments in tuberculosis (TB) active case finding (ACF) but costing and cost-effectiveness analyses are limited. We provide implementation cost and cost-effectiveness estimates of different screening algorithms using symptoms, CXR and AI in Nigeria. People 15 years and older were screened for TB symptoms and offered a CXR with AI-enabled interpretation using qXR v3 (Qure.ai) at lung health camps. Sputum samples were tested on Xpert MTB/RIF for individuals reporting symptoms or with qXR abnormality scores ≥0.30. We conducted a retrospective costing using a combination of top-down and bottom-up approaches while utilizing itemized expense data from a health system perspective. We estimated costs in five screening scenarios: abnormality score ≥0.30 and ≥0.50; cough ≥ 2 weeks; any symptom; abnormality score ≥0.30 or any symptom. We calculated total implementation costs, cost per bacteriologically-confirmed case detected, and assessed cost-effectiveness using incremental cost-effectiveness ratio (ICER) as additional cost per additional case. Overall, 3205 people with presumptive TB were identified, 1021 were tested, and 85 people with bacteriologically-confirmed TB were detected. Abnormality ≥ 0.30 or any symptom (US$65704) had the highest costs while cough ≥ 2 weeks was the lowest (US$40740). The cost per case was US$1198 for cough ≥ 2 weeks, and lowest for any symptom (US$635). Compared to baseline strategy of cough ≥ 2 weeks, the ICER for any symptom was US$191 per additional case detected and US$ 2096 for Abnormality ≥0.30 OR any symptom algorithm. Using CXR and AI had lower cost per case detected than any symptom screening criteria when asymptomatic TB was higher than 30% of all bacteriologically-confirmed TB detected. Compared to traditional symptom screening, using CXR and AI in combination with symptoms detects more cases at lower cost per case detected and is cost-effective. TB programs should explore adoption of CXR and AI for screening in ACF.

Current anomaly detection methods excel with benchmark industrial data but struggle with natural images and medical data due to varying definitions of 'normal' and 'abnormal.' This makes accurate identification of deviations in these fields particularly challenging. Especially for 3D brain MRI data, all the state-of-the-art models are reconstruction-based with 3D convolutional neural networks which are memory-intensive, time-consuming and producing noisy outputs that require further post-processing. We propose a framework called Simple Slice-based Network (SimpleSliceNet), which utilizes a model pre-trained on ImageNet and fine-tuned on a separate MRI dataset as a 2D slice feature extractor to reduce computational cost. We aggregate the extracted features to perform anomaly detection tasks on 3D brain MRI volumes. Our model integrates a conditional normalizing flow to calculate log likelihood of features and employs the contrastive loss to enhance anomaly detection accuracy. The results indicate improved performance, showcasing our model's remarkable adaptability and effectiveness when addressing the challenges exists in brain MRI data. In addition, for the large-scale 3D brain volumes, our model SimpleSliceNet outperforms the state-of-the-art 2D and 3D models in terms of accuracy, memory usage and time consumption. Code is available at: https://github.com/Jarvisarmy/SimpleSliceNet.

Osteoporosis, a prevalent skeletal disorder, necessitates accurate and accessible diagnostic tools for effective disease management and fracture prevention. While dual-energy X-ray absorptiometry (DXA) remains the clinical standard for bone mineral density (BMD) assessment, its limitations, including ionizing radiation exposure and susceptibility to artifacts, underscore the need for alternative technologies. Ultrasound-based methods have emerged as promising radiation-free alternatives, with radiofrequency echographic multi-spectrometry (REMS) representing a significant advancement in axial skeleton assessment, specifically at the lumbar spine and proximal femur. REMS analyzes unfiltered radiofrequency ultrasound signals, providing not only BMD estimates but also a novel fragility score (FS), which reflects bone quality and microarchitectural integrity. This review critically evaluates the underlying principles, diagnostic performance, and clinical applications of REMS. It compares REMS with DXA, quantitative computed tomography (QCT), and trabecular bone score (TBS), highlighting REMS's potential advantages in artifact-prone scenarios and specific populations, including children and patients with secondary osteoporosis. The clinical utility of REMS in fracture risk prediction and therapy monitoring is explored alongside its operational precision, cost-effectiveness, and portability. In addition, the integration of artificial intelligence (AI) within REMS software has enhanced its capacity for artifact exclusion and automated spectral interpretation, improving usability and reproducibility. Current limitations, such as the need for broader validation and guideline inclusion, are identified, and future research directions are proposed. These include multicenter validation studies, development of pediatric and secondary osteoporosis reference models, and deeper evaluation of AI-driven enhancements. REMS offers a compelling, non-ionizing alternative for axial bone health assessment and may significantly advance the diagnostic landscape for osteoporosis care.

Hip fractures are a major orthopedic problem, especially in the elderly population. Hip fractures are usually diagnosed by clinical evaluation and imaging, especially X-rays. In recent years, new approaches to fracture detection have emerged with the use of artificial intelligence (AI) and deep learning techniques in medical imaging. In this study, we aimed to evaluate the diagnostic performance of ChatGPT-4o, an artificial intelligence model, in diagnosing hip fractures. A total of 200 anteroposterior pelvic X-ray images were retrospectively analyzed. Half of the images belonged to patients with surgically confirmed hip fractures, including both displaced and non-displaced types, while the other half represented patients with soft tissue trauma and no fractures. Each image was evaluated by ChatGPT-4o through a standardized prompt, and its predictions (fracture vs. no fracture) were compared against the gold standard diagnoses. Diagnostic performance metrics such as sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), receiver operating characteristic (ROC) curve, Cohen's kappa, and F1 score were calculated. ChatGPT-4o demonstrated an overall accuracy of 82.5% in detecting hip fractures on pelvic radiographs, with a sensitivity of 78.0% and specificity of 87.0%. PPVs and NPVs were 85.7% and 79.8%, respectively. The area under the ROC curve (AUC) was 0.825, indicating good discriminative performance. Among 22 false-negative cases, 68.2% were non-displaced fractures, suggesting the model had greater difficulty identifying subtle radiographic findings. Cohen's kappa coefficient was 0.65, showing substantial agreement with actual diagnoses. Chi-square analysis revealed a strong correlation (χ² = 82.59, <i>P</i> < 0.001), while McNemar's test (<i>P</i> = 0.176) showed no significant asymmetry in error distribution. ChatGPT-4o shows promising accuracy in identifying hip fractures on pelvic X-rays, especially when fractures are displaced. However, its sensitivity drops significantly for non-displaced fractures, leading to many false negatives. This highlights the need for caution when interpreting negative AI results, particularly when clinical suspicion remains high. While not a replacement for expert assessment, ChatGPT-4o may assist in settings with limited specialist access.

Two of the most common complaints seen in neurology clinics are Alzheimer's disease (AD) and mild cognitive impairment (MCI), characterized by similar symptoms. The aim of this study was to develop and internally validate the diagnostic value of combined neurological and radiological predictors in differentiating mild AD from MCI as the outcome variable, which helps in preventing AD development. A cross-sectional study of 161 participants was conducted in a general healthcare setting, including 30 controls, 71 mild AD, and 60 MCI. Binary logistic regression was used to identify predictors of interest, with collinearity assessment conducted prior to model development. Model performance was assessed through calibration, shrinkage, and decision-curve analyses. Finally, the combined clinical and radiological model was compared to models utilizing only clinical or radiological predictors. The final model included age, sex, education status, Montreal cognitive assessment, Global Cerebral Atrophy Index, Medial Temporal Atrophy Scale, mean hippocampal volume, and Posterior Parietal Atrophy Index, with the area under the curve of 0.978 (0.934-0.996). Internal validation methods did not show substantial reduction in diagnostic performance. Combined model showed higher diagnostic performance compared to clinical and radiological models alone. Decision curve analysis highlighted the usefulness of this model for differentiation across all probability levels. A combined clinical-radiological model has excellent diagnostic performance in differentiating mild AD from MCI. Notably, the model leveraged straightforward neuroimaging markers, which are relatively simple to measure and interpret, suggesting that they could be integrated into practical, formula-driven diagnostic workflows without requiring computationally intensive deep learning models.

Brain-wide association studies (BWASs) have attempted to relate cognitive abilities with brain phenotypes, but have been challenged by issues such as predictability, test-retest reliability, and cross-cohort generalizability. To tackle these challenges, we proposed a machine learning "stacking" approach that draws information from whole-brain MRI across different modalities, from task-functional MRI (fMRI) contrasts and functional connectivity during tasks and rest to structural measures, into one prediction model. We benchmarked the benefits of stacking using the Human Connectome Projects: Young Adults (<i>n</i> = 873, 22-35 years old) and Human Connectome Projects-Aging (<i>n</i> = 504, 35-100 years old) and the Dunedin Multidisciplinary Health and Development Study (Dunedin Study, <i>n</i> = 754, 45 years old). For predictability, stacked models led to out-of-sample <i>r</i>∼0.5-0.6 when predicting cognitive abilities at the time of scanning, primarily driven by task-fMRI contrasts. Notably, using the Dunedin Study, we were able to predict participants' cognitive abilities at ages 7, 9, and 11 years using their multimodal MRI at age 45 years, with an out-of-sample <i>r</i> of 0.52. For test-retest reliability, stacked models reached an excellent level of reliability (interclass correlation > 0.75), even when we stacked only task-fMRI contrasts together. For generalizability, a stacked model with nontask MRI built from one dataset significantly predicted cognitive abilities in other datasets. Altogether, stacking is a viable approach to undertake the three challenges of BWAS for cognitive abilities.

This study investigates the feasibility of reducing manual image annotation costs in medical image database construction by utilizing a step by step approach where the Artificial Intelligence model (AI model) trained on a previous batch of data automatically pre-annotates the next batch of image data, taking ultrasound image of thyroid nodule annotation as an example. The study used YOLOv8 as the AI model. During the AI model training, in addition to conventional image augmentation techniques, augmentation methods specifically tailored for ultrasound images were employed to balance the quantity differences between thyroid nodule classes and enhance model training effectiveness. The study found that training the model with augmented data significantly outperformed training with raw images data. When the number of original images number was only 1,360, with 7 thyroid nodule classifications, pre-annotation using the AI model trained on augmented data could save at least 30% of the manual annotation workload for junior physicians. When the scale of original images number reached 6,800, the classification accuracy of the AI model trained on augmented data was very close with that of junior physicians, eliminating the need for manual preliminary annotation.

The aim of this investigation is to assess the clinical usefulness of a machine learning model using contrast-enhanced ultrasound (CEUS) radiomics in discriminating clear cell renal cell carcinoma (ccRCC) from non-ccRCC. A total of 292 patients with pathologically confirmed RCC subtypes underwent CEUS (development set. n = 231; validation set, n = 61) in a retrospective study. Radiomics features were derived from CEUS images acquired during the cortical and parenchymal phases. Radiomics models were developed using logistic regression (LR), support vector machine, decision tree, naive Bayes, gradient boosting machine, and random forest. The suitable model was identified based on the area under the receiver operating characteristic curve (AUC). Appropriate clinical CEUS features were identified through univariate and multivariate LR analyses to develop a clinical model. By integrating radiomics and clinical CEUS features, a combined model was established. A comprehensive evaluation of the models' performance was conducted. After the reduction and selection process were applied to 2250 radiomics features, the final set of 8 features was considered valuable. Among the models, the LR model had the highest performance on the validation set and showed good robustness. In both the development and validation sets, both the radiomics (AUC, 0.946 and 0.927) and the combined models (AUC, 0.949 and 0.925) outperformed the clinical model (AUC, 0.851 and 0.768), showing higher AUC values (all p < 0.05). The combined model exhibited favorable calibration and clinical benefit. The combined model integrating clinical CEUS and CEUS radiomics features demonstrated good diagnostic performance in discriminating ccRCC from non-ccRCC.

Since its development, virtual monoenergetic imaging (VMI) derived from dual-energy computed tomography (DECT) has been shown to be valuable in many clinical applications. However, DECT-based VMI showed increased noise at low keV levels. In this study, we proposed an unsupervised learning method to generate VMI from DECT. This means that we don't require training and labeled (i.e. high-quality VMI) data. Specifically, DECT images were fed into a deep learning (DL) based model expected to output VMI. Based on the theory that VMI obtained from image space data is a linear combination of DECT images, we used the model output (i.e. the predicted VMI) to recalculate DECT images. By minimizing the difference between the measured and recalculated DECT images, the DL-based model can be constrained itself to generate VMI from DECT images. We investigate whether the proposed DL-based method has the ability to improve the quality of VMIs. The experimental results obtained from patient data showed that the DL-based VMIs had better image quality than the conventional DECT-based VMIs. Moreover, the CT number differences between the DECT-based and DL-based VMIs were distributed within <math xmlns="http://www.w3.org/1998/Math/MathML"><mo>±</mo></math> 10 HU for bone and <math xmlns="http://www.w3.org/1998/Math/MathML"><mo>±</mo></math> 5 HU for brain, fat, and muscle. Except for bone, no statistically significant difference in CT number measurements was found between the DECT-based and DL-based VMIs (p > 0.01). Our preliminary results show that DL has the potential to unsupervisedly generate high-quality VMIs directly from DECT.

Investigate spleen diameter (d) and volume (v) relationship in patients with hematologic malignancies (HM) by determining volumetric thresholds that best correlate to established diameter thresholds for assessing response to treatment. Exploratorily, interrogate the impact of volumetric measurements in response categories and as a predictor of response. Secondary analysis of prospectively collected clinical trial data of 382 patients with HM. Spleen diameters were computed following Lugano criteria and volumes using deep learning segmentation. d and v relationship was estimated using power regression model, volumetric thresholds ([Formula: see text]) for treatment response estimated; threshold search to determine percentual change ([Formula: see text] and minimum volumetric increase ([Formula: see text]) that maximize agreement with Lugano criteria performed. Spleen diameter and volume predictive performance for clinical response investigated using random forest model. [Formula: see text] describes the relationship between spleen diameter and volume. [Formula: see text] for splenomegaly was 546 cm³. [Formula: see text], [Formula: see text], and [Formula: see text] for assessing response resulting in highest agreement with Lugano criteria were 570 cm³, 73%, and 170 cm³, respectively. Predictive performance for response between diameter and volume were not significantly different (P=0.78). This study provides empirical spleen volume threshold and percentual changes that best correlate with diameter thresholds, i.e., Lugano criteria, for assessment of response to treatment in patients with HM. In our dataset use of spleen volumetric thresholds versus diameter thresholds resulted in similar response assessment categories and did not signal differences in predictive values for response.